从“试验田”到“丰收地”

Group 1 - The "Lecang speed" allows for expedited approval processes for innovative medical devices and drugs, significantly reducing the typical 48-month approval timeline to just 17 months for certain products [1] - The introduction of the "全飞秒 VISUMAX 800" device at the China International Import Expo has garnered significant attention, highlighting the advancements in laser corneal refractive surgery technology [1] - Three products, including the Carl Zeiss femtosecond laser and Sanofi's anti-CD38 monoclonal antibody, have received approval in China this year, showcasing the effectiveness of the real-world research pilot program [1] Group 2 - The first global innovation medical device expo in Hainan featured high-profile live surgeries utilizing advanced robotic technology, demonstrating the integration of cutting-edge medical devices into clinical practice [2] - The use of robotic arms in surgeries allows for precise electrode delivery at a speed of 0.1 mm/second, enhancing the safety and effectiveness of procedures like cochlear implantation [2] - The establishment of a regional real-world data platform and an ethics review committee in the Hainan Boao Lecheng area supports the rapid clinical application of international auditory technologies [2] Group 3 - The real-world research initiative in Lecheng is transforming the area into a hub for medical innovation, benefiting patients through improved access to advanced healthcare solutions [3]